GSK-115158

Study Sponsor: GSK

Study Title

Immunogenicity and safety study of GSK Biologicals’ combined measles-mumps-rubella vaccine in subjects four to six years of age (209762)

Medicine or Vaccine (generic name)

Measles, Mumps, Rubella Vaccine

Sponsor Identification Number

115158

Trial Registry Identification Number(#'s)

NCT01621802 2011-004638-32

Medical Condition

Measles, Mumps, Rubella

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

March 2019